Affiliations 

  • 1 School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800 USM Penang, Malaysia
  • 2 Advanced Medical and Dental Institute (AMDI), Universiti Sains Malaysia, 13200 USM Penang, Malaysia. Electronic address: ramaballouze@gmail.com
  • 3 Advanced Medical and Dental Institute (AMDI), Universiti Sains Malaysia, 13200 USM Penang, Malaysia
Diabetes Res Clin Pract, 2020 Aug;166:108293.
PMID: 32623035 DOI: 10.1016/j.diabres.2020.108293

Abstract

AIMS: COVID-19 is a current global pandemic. However, comprehensive global data analyses for its mortality risk factors are lacking. The current investigation aimed to assess the predictors of death among COVID-19 patients from worldwide open access data.

METHODS: A total of 828 confirmed cases of COVID-19 with definite outcomes were retrospectively identified from open access individual-level worldwide data. Univariate followed by multivariable regression analysis were used to evaluate the association between potential risk factors and mortality.

RESULTS: Majority of the patients were males 59.1% located in Asia 69.3%. Based on the data, older age (adjusted odds ratio (aOR), 1.079; 95% confidence intervals (95% CI), 1.064-1.095 per year increase), males (aOR, 1.607; 95% CI, 1.002-2.576), patients with hypertension (aOR, 3.576; 95% CI, 1.694-7.548), diabetes mellitus (aOR, 12.234; 95% CI, 4.126-36.272), and patients located in America (aOR, 7.441; 95% CI, 3.546-15.617) were identified as the risk factors of mortality among COVID-19 patients.

CONCLUSIONS: Males, advanced age, hypertension patients, diabetes mellitus patients, and patients located in America were the independent risk factors of death among COVID-19 patients. Extra attention is required to be given to these factors and additional studies on the underlying mechanisms of these effects.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.